Proxima Therapeutics Announces FDA Approval of GliaSite(R) Radiation Therapy System for Brain Tumors
(PR Newswire)Proxima Therapeutics Inc., a developer and marketer of site-specific cancer treatments, today announced that its GliaSite Radiation Therapy System treatment for brain tumors has received marketing clearance from the United States Food and Drug Administration, its first product to receive FDA approval.- May 08 8:05 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010508/cgtu032.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines